BetterLife Pharma has appointed Sheila Leitzinger as Head of Clinical Operations to lead the initial healthy volunteer study of its neurological drug candidate BETR-001. Leitzinger brings nearly 30 years of experience in clinical development, including managing global and first-in-human trials. This study is a critical first step before advancing BETR-001 into trials for chronic cluster headache and migraine. BETR-001 is a non-hallucinogenic LSD derivative designed to treat neurological disorders and is unique for being unregulated and self-administered, with patent protection until around 2042.
BetterLife Pharma's leadership update comes with this snapshot of the health sector on Pluang. Of 150 priced health-sector US stocks, 93 rose and 49 fell. Notable movers include BNGO at USD 1.28 with a 1-day change of -6.57% and 100% buy order activity, TWST at USD 140.08 down 5.45%, and TXG at USD 69.94 down 4.32%. Data is as of Oct 15, 2026 18:13 WIB.
TiDB, powered by PingCAP, announced new cloud platform capabilities to support enterprise and AI applications on a unified data foundation. Key updates include the upcoming general availability of TiDB Cloud Premium, public previews of Bring Your Own...
The Saudi Arabia Non-Invasive Prenatal Testing (NIPT) market is projected to grow from $52.5 million in 2025 to $162.16 million by 2034, at a CAGR of 13.35%. Growth is fueled by rising maternal age, advances in molecular diagnostics, and increased he...
ONEOK completed a $4.425 billion acquisition of Brazos Midstream's natural gas assets, doubling its processing capacity in the Permian Midland Basin to about 2.3 billion cubic feet per day. The deal secures 600,000 acres under long-term contracts, st...
Charles Schwab reported Q3 earnings per share of $1.69, beating estimates despite slightly missing revenue forecasts with $7.17 billion. The quarter marked a 17% revenue increase year-over-year and a 23% rise in net income to $2.91 billion, driven by...
Alcoa will release its Q3 2026 earnings on October 15, with analysts divided on earnings per share and revenue forecasts due to factors like rising aluminum sales, inventory changes, and higher input costs. The company expects a 54.9% jump in aluminu...
